Pre- and post-operative high blood levels of CD26+/CD326− cells conditioned a probability of tumor relapse that was, respectively, 11 and 18 times higher than that observed in patients who had no detectable blood levels of CD26+/CD326− cells. This evidence concerns the gene EPCAM and neoplasm.